Table 1 Clinicopathologic characteristics of patients with oral squamous cell carcinoma.

From: Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system

Parameter

Number (%)

Total

291

Age, years

Median (range)

63 (24–91)

< 63 years

142 (48.8)

≥ 63 years

149 (51.2)

Sex

Male

108 (37.1)

Female

183 (62.9)

Smoking history

Yes

183 (62.9)

No

108 (37.1)

Alcohol history

Yes

161 (54.9)

No

132 (45.1)

CCI

0–2 points

283 (97.3)

≥ 3 points

8 (2.7)

Location of primary tumor

Tongue

77 (26.5)

FOM

22 (7.6)

RMT

36 (12.4)

Mandibular gingiva

85 (29.2)

Lip

7 (2.4)

Buccal cheek mucosa

42 (14.4)

Maxilla

22 (7.6)

AJCC pT categories

pT1

78 (26.8)

pT2

85 (29.2)

pT3

35 (12.0)

pT4a

91 (31.3)

pT4b

2 (0.7)

AJCC pN categories

pN0

199 (68.4)

pN1

21 (7.2)

pN2

35 (12.0)

pN3

36 (12.4)

AJCC staging

I

67 (23.0)

II

63 (21.6)

III

35 (12.0)

IVA

89 (30.6)

IVB

37 (12.7)

Adverse pathologic features

Lymphovascular permeation

39 (13.4)

Perineural invasion

33 (11.3)

Extranodal extension

40 (13.7)

NA

1 (0.3)

Resection margin status

Positive

28 (9.6)

Close (\(\le\) 5 mm)

93 (32.0)

Negative (> 5 mm)

169 (58.1)

NA

1 (0.3)

Adjuvant therapy

RTx alone

53 (18.2)

CTx alone

2 (0.7)

CCRT

65 (22.3)

None

171 (58.8)

Relapse

Loco-regional relapse

66 (22.7)

Distant relapse

1 (0.3)

None

224 (77.0)

Survival status

Alive

241 (82.8)

Dead

50 (17.2)

  1. CCI Charlson comorbidity index, FOM floor of mouth, RMT retromolar trigone, AJCC American Joint Committee on Cancer, pT pathologic primary tumor categories, pN pathologic regional lymph node categories, NA not applicable, RTx radiotherapy, CTx chemotherapy, CCRT concurrent chemoradiotherapy.